Clinical Trials Arena on MSN1d
MediWound commences Phase III trial for venous leg ulcers treatmentMediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...
Recent research into bacterial cellulose patches may speed plants' recovery, improve grafting and help with preservation.
YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback